Stifel Financial Corp Omeros Corp Transaction History

Stifel Financial Corp

  • $93.2 Billion
  • Q3 2024

A detailed history of Stifel Financial Corp transactions in Omeros Corp stock. As of the latest transaction made, Stifel Financial Corp holds 1,904,207 shares of OMER stock, worth $15 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,904,207
Previous 1,902,594 0.08%
Holding current value
$15 Million
Previous $7.72 Million 2.14%
% of portfolio
0.01%
Previous 0.01%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$3.54 - $5.47 $5,710 - $8,823
1,613 Added 0.08%
1,904,207 $7.56 Million
Q2 2024

Aug 13, 2024
SELL
$3.04 - $4.23 $19,866 - $27,643
-6,535 Reduced 0.34%
1,902,594 $7.72 Million
Q1 2024

May 13, 2024
BUY
$2.88 - $4.89 $53,150 - $90,244
18,455 Added 0.98%
1,909,129 $6.59 Million
Q4 2023

Feb 12, 2024
SELL
$1.08 - $3.63 $148,222 - $498,192
-137,243 Reduced 6.77%
1,890,674 $6.18 Million
Q3 2023

Nov 13, 2023
SELL
$2.81 - $5.69 $81,259 - $164,543
-28,918 Reduced 1.41%
2,027,917 $5.92 Million
Q2 2023

Aug 14, 2023
BUY
$4.45 - $7.57 $414,806 - $705,637
93,215 Added 4.75%
2,056,835 $11.2 Million
Q1 2023

May 12, 2023
BUY
$2.48 - $5.22 $1.26 Million - $2.64 Million
506,569 Added 34.77%
1,963,620 $9.13 Million
Q4 2022

Feb 13, 2023
BUY
$1.75 - $3.96 $130,107 - $294,414
74,347 Added 5.38%
1,457,051 $3.29 Million
Q3 2022

Nov 14, 2022
BUY
$3.09 - $7.46 $241,801 - $583,767
78,253 Added 6.0%
1,382,704 $4.36 Million
Q2 2022

Aug 15, 2022
BUY
$1.92 - $6.28 $212,578 - $695,309
110,718 Added 9.27%
1,304,451 $3.59 Million
Q1 2022

May 13, 2022
BUY
$5.07 - $7.2 $1.16 Million - $1.64 Million
228,430 Added 23.66%
1,193,733 $7.17 Million
Q4 2021

Feb 14, 2022
SELL
$5.67 - $8.54 $350,077 - $527,276
-61,742 Reduced 6.01%
965,303 $6.21 Million
Q3 2021

Nov 15, 2021
BUY
$13.4 - $16.3 $390,007 - $474,411
29,105 Added 2.92%
1,027,045 $14.2 Million
Q2 2021

Aug 13, 2021
BUY
$14.81 - $19.13 $665,398 - $859,491
44,929 Added 4.71%
997,940 $14.8 Million
Q1 2021

May 14, 2021
SELL
$14.52 - $23.53 $154,086 - $249,700
-10,612 Reduced 1.1%
953,011 $17 Million
Q4 2020

Feb 12, 2021
BUY
$10.14 - $15.19 $500,814 - $750,234
49,390 Added 5.4%
963,623 $13.8 Million
Q3 2020

Nov 16, 2020
BUY
$9.57 - $21.32 $669,450 - $1.49 Million
69,953 Added 8.29%
914,233 $9.24 Million
Q2 2020

Aug 14, 2020
SELL
$12.21 - $16.99 $59,303 - $82,520
-4,857 Reduced 0.57%
844,280 $12.4 Million
Q1 2020

May 14, 2020
SELL
$9.03 - $19.72 $80,800 - $176,454
-8,948 Reduced 1.04%
849,137 $11.3 Million
Q4 2019

Feb 13, 2020
BUY
$13.01 - $17.15 $1.52 Million - $2.01 Million
117,126 Added 15.81%
858,085 $12.1 Million
Q3 2019

Nov 13, 2019
BUY
$14.55 - $20.56 $929,614 - $1.31 Million
63,891 Added 9.44%
740,959 $12.1 Million
Q2 2019

Aug 14, 2019
BUY
$15.0 - $19.62 $638,655 - $835,360
42,577 Added 6.71%
677,068 $10.6 Million
Q1 2019

May 14, 2019
BUY
$11.65 - $17.72 $2.22 Million - $3.38 Million
190,813 Added 43.01%
634,491 $11 Million
Q4 2018

Feb 13, 2019
SELL
$10.72 - $16.73 $260,914 - $407,191
-24,339 Reduced 5.2%
443,678 $4.94 Million
Q3 2018

Nov 13, 2018
BUY
$17.73 - $26.69 $46,204 - $69,554
2,606 Added 0.56%
468,017 $11.4 Million
Q2 2018

Aug 14, 2018
BUY
$10.79 - $24.44 $1.26 Million - $2.85 Million
116,685 Added 33.46%
465,411 $8.44 Million
Q1 2018

May 11, 2018
BUY
$9.0 - $20.16 $58,806 - $131,725
6,534 Added 1.91%
348,726 $3.9 Million
Q4 2017

Feb 14, 2018
SELL
$13.26 - $22.86 $692,649 - $1.19 Million
-52,236 Reduced 13.24%
342,192 $6.66 Million
Q3 2017

Nov 13, 2017
BUY
$19.76 - $24.9 $7.79 Million - $9.82 Million
394,428
394,428 $0

Others Institutions Holding OMER

# of Institutions
120
Shares Held
25.6M
Call Options Held
228K
Put Options Held
630K
View Full List

About OMEROS CORP

OMER Quotes by TradingView
  • Ticker OMER
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,730,000
  • Market Cap $494M
  • Description
  • Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...
More about OMER
Track This Portfolio

Track Stifel Financial Corp Portfolio

Follow Stifel Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Stifel Financial Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email